Skip to main content
. 2018 Feb 8;6(2):2325967117752623. doi: 10.1177/2325967117752623

TABLE 3.

Treatment Characteristicsa

General Study Population Patients Requiring Revision Surgery % of Revision Surgery With Regard to Entire Cohort P Value
Type of surgery .2914
 ACI 1100 (41.37) 50 (4.54) 1.88
 Bone marrow  stimulation 497 (18.69) 15 (3.02) 0.56
 ACI with  subchondral  bone  reconstruction 195 (7.33) 6 (3.08) 0.23
 Osteochondral  autograft 58 (2.18) 3 (5.17) 0.11
 MACI 92 (3.46) 2 (2.17) 0.08
 Defect  debridement 127 (4.78) 1 (0.79) 0.04
 Multiple 211 (7.94) 3 (1.42) 0.11
 Other 291 (10.94) 8 (2.75) 0.30
No. of previous knee operative procedures .0203
  None 1275 (47.95) 29 (2.27) 1.09
  1 procedure 759 (28.54) 29 (3.82) 1.09
  2 procedures 299 (11.24) 17 (5.69) 0.64
  >2 procedures 203 (7.63) 12 (5.91) 0.45
  Not reported 35 (1.32) 1 (2.86) 0.04
No. of surgeries for cartilage defect .0749
  None 1998 (75.14) 59 (2.95) 2.22
  1 surgery 416 (15.64) 20 (4.81) 0.75
  2 surgeries 83 (3.12) 6 (7.23) 0.23
  >2 surgeries 30 (1.13) 2 (6.67) 0.08
  Not reported 44 (1.65) 1 (2.27) 0.04

aData are shown as n (%) unless otherwise indicated. ACI, autologous chondrocyte implantation; MACI, matrix-induced autologous chondrocyte implantation.